DCP
AZN icon

DSM Capital Partners’s AstraZeneca AZN Stock Holding History

DSM Capital Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-163
Closed -$22.1K – 103
2024
Q1 		$22.1K Buy
163
+51
+46% +$6.75K ﹤0.01% 99
2023
Q4 		$15K Sell
112
-19,854
-99% -$2.58M ﹤0.01% 115
2023
Q3 		$2.7M Sell
19,966
-864,610
-98% -$118M 0.05% 35
2023
Q2 		$127M Sell
884,576
-159,775
-15% -$23.5M 2.05% 19
2023
Q1 		$145M Sell
1,044,351
-70,193
-6% -$9.44M 2.37% 17
2022
Q4 		$151M Sell
1,114,544
-27,044
-2% -$3.39M 2.51% 15
2022
Q3 		$125M Sell
1,141,588
-6,030
-0.5% -$765K 2.12% 19
2022
Q2 		$152M Buy
1,147,618
+878,109
+326% +$115M 2.54% 13
2022
Q1 		$35.8M Buy
269,509
+18,311
+7% +$2.2M 0.48% 28
2021
Q4 		$29.3M Buy
251,198
+43,888
+21% +$5.16M 0.31% 29
2021
Q3 		$24.9M Buy
207,310
+24,417
+13% +$2.84M 0.26% 28
2021
Q2 		$21.9M Sell
182,893
-34,276
-16% -$3.76M 0.21% 28
2021
Q1 		$21.6M Buy
217,169
+18,206
+9% +$1.83M 0.23% 29
2020
Q4 		$19.9M Buy
198,963
+162,383
+444% +$17.2M 0.21% 28
2020
Q3 		$4.01M Buy
36,580
+125
+0.3% +$13.9K 0.04% 33
2020
Q2 		$3.86M Buy
+36,455
New +$3.76M 0.05% 34

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DSM Capital Partners's AZN Position: Q2 2024 in Review

DSM Capital Partners sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 163 shares — an estimated $22.1K sold.

DSM Capital Partners first reported a position in AZN in Q2 2020 and held it in 16 quarters. The position peaked at $152M in Q2 2022. 1,211 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

  • DSM Capital Partners reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
  • DSM Capital Partners sold 163 AstraZeneca shares in Q2 2024, an estimated $22.1K.
  • DSM Capital Partners first reported a position in AstraZeneca in Q2 2020 and held it in 16 quarters.
  • DSM Capital Partners's AstraZeneca position peaked at $152M in Q2 2022.
  • 1,211 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on DSM Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.